Clinical Trials Directory

Trials / Completed

CompletedNCT01005784

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

Fixed Versus Flexible GnRH Antagonist Initiation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
Female
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

This is a comparison of pregnancy achievement between two GnRH antagonist protocols which differ in the timing of GnRH antagonist initiation.

Conditions

Interventions

TypeNameDescription
DRUGCetrorelix (Cetrotide)flexible antagonist administration according to specified criteria
DRUGCetrorelix (Cetrotide)fixed antagonist administration on day 6 of ovarian stimulation

Timeline

Start date
2005-06-01
Primary completion
2008-01-01
Completion
2008-03-01
First posted
2009-11-02
Last updated
2009-11-02

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01005784. Inclusion in this directory is not an endorsement.

Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation (NCT01005784) · Clinical Trials Directory